Publications by authors named "Rebeca Alba Rubio"

11Publications

Pappalysin-1 T cell receptor transgenic allo-restricted T cells kill Ewing sarcoma and .

Oncoimmunology 2017 17;6(2):e1273301. Epub 2017 Jan 17.

Laboratory for Functional Genomics and Transplantation Biology, Department of Pediatrics and Children's Cancer Research Center, Klinikum rechts der Isar, Technische Universität München , München, Germany.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/2162402X.2016.1
Publisher Site
http://dx.doi.org/10.1080/2162402X.2016.1273301DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353903PMC
January 2017

Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity.

Oncoimmunology 2016 Jun 25;5(6):e1175795. Epub 2016 Apr 25.

Children's Cancer Research Center and Department of Pediatrics, Klinikum rechts der Isar, Technische Universität München, Munich, Germany and Comprehensive Cancer Center Munich (CCCM) , Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1175795DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938321PMC
June 2016

Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T cells specifically inhibit Ewing sarcoma growth in vitro and in vivo.

Oncotarget 2016 Jul;7(28):43267-43280

Laboratory for Functional Genomics and Transplantation Biology, Department of Pediatrics and Children's Cancer Research Center, Klinikum rechts der Isar, Technische Universitaet Muenchen, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.9218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190022PMC
July 2016